News and Insights of 3D Printing and Manufacturing
3D printing company EnvisionTEC has taken a significant step ahead in the development of 3D printed nasal swabs for COVID-19 testing. It has just announced that it has successfully completed a clinical trial for the testing swabs and, along with several of its FDA-registered customers, will begin producing up to 1 million swabs per day using the Envision One cDLM platform.
We have discovered that coral reefs around the globe are perishing due to the acidity of seawater an ...
American filament firm 3D Printlife has announced it is donating 4,000 kg of PLA to encourage the cr ...
Prisma Health is collaborating with Ethicon Inc., part of the Johnson & Johnson Medical Devices Companies, to make and distribute a ventilator expansion device, called the VESper™ Ventilator Expansion Splitter. The VESper Ventilator Expansion Splitter is authorized for emergency use only to allow a single ventilator to be fitted with the Ventilator Splitter to be used for two rescuable patients for ventilatory support during the COVID-19 pandemic until individual ventilators are available.
Massachusetts-based 3D printing company Markforged has just announced a partnership with optical equipment provider Neurophotometrics (NPM) to produce 3D printed nasopharyngeal swabs for COVID-19 diagnostic testing. The swab design, called Fiberflex Rayon, reportedly detected the virus in all patients tested, while commercial swabs reported false negatives. Markforged says it is now producing 10,000 nasal swabs per day and plans to scale production up to 100,000 per day.
FabRx Ltd., a biotech spin-out from University College London (UCL) in the UK, has announced the availability of its M3DIMAKER system, the first pharmaceutical 3D printer developed for the production of customized medicine. The system was first unveiled in Switzerland in September 2019 at the ILMAC Exhibition and now, after extensive testing, it is ready for the market.
On November 19, 2019, the world's largest 3D printing professional exhibition, FORMNEXT, was held ...
As has quickly become apparent in the fight against COVID-19, one of the critical factors in stemming the spread of the virus and understanding its reach is widespread testing. The World Health Organization (WHO) has promoted testing in its guidance to governments, but on the ground many countries have struggled to scale up testing operations to the point required. One of the key inhibitors to adopting more broad testing is a lack of supplies, including test kits and personal protective equipment for healthcare workers.
All aspects of daily life are slowly but surely affecting by COVID-19. For many countries, ...
The imminent shortage of ventilators for U.S. hospitals is most probably already a crisis, but may b ...